Form 4: Forbion Growth Opportunities Fund I Acquires Shares in enGene Holdings Inc.

Forbion Growth Opportunities Fund I Cooperatief U.A. acquired 561,797 common shares of enGene Holdings Inc. in a private placement and disposed of 3,032,430 shares.

Summary

• On October 30, 2024, Forbion Growth Opportunities Fund I Cooperatief U.A. acquired 561,797 common shares of enGene Holdings Inc. through a private placement at a price of $8.9 per share.
• The acquisition was made pursuant to a Subscription Agreement dated October 24, 2024.
• Following the transaction, Forbion Cooperatief directly holds 3,032,430 common shares.
• Additionally, 3,765,932 shares are held indirectly by Forbion Growth Sponsor FEAC I B.V., which is wholly owned by Forbion Cooperatief.
• Forbion Growth Management B.V. exercises voting and investment power over Forbion Cooperatief through its investment committee.
• The reporting persons disclaim beneficial ownership of the securities except to the extent of their pecuniary interest.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard disclosure of share transactions. The acquisition of shares could be seen as a positive signal, but the disposal of shares offsets this.

Positives

• The acquisition of shares through a private placement indicates continued investment and confidence in enGene Holdings Inc. by Forbion Growth Opportunities Fund I Cooperatief U.A.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders or significant shareholders of a publicly traded company buy or sell shares. This filing indicates changes in ownership by a major shareholder, Forbion Growth Opportunities Fund I Cooperatief U.A., which is relevant to investors monitoring the stock.

Stakeholder Impact

• The change in share ownership may influence investor sentiment and potentially affect the stock price of enGene Holdings Inc.

Key Dates